EDGAR Filing Documents for 0001193125-13-242429

Form 8-K - Current report:

SEC Accession No. 0001193125-13-242429

Filing Date

2013-05-31

Accepted

2013-05-31 08:01:24

Documents

Period of Report

2013-05-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d546764d8k.htm	8-K	27426
2	EX-2.1	d546764dex21.htm	EX-2.1	402853
3	EX-10.1	d546764dex101.htm	EX-10.1	125081
4	EX-99.1	d546764dex991.htm	EX-99.1	18843
5	GRAPHIC	g546764ex991a.jpg	GRAPHIC	50504
6	GRAPHIC	g546764ex991b.jpg	GRAPHIC	7196
	Complete submission text file	0001193125-13-242429.txt		655367

Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9

Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792

Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)